
Global Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Regional Outlook and Forecast, 2024 - 2031
Description
Global Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Regional Outlook and Forecast, 2024 - 2031
The Global Cat Vaccine Market size is expected to reach $2.5 billion by 2031, rising at a market growth of 9.2% CAGR during the forecast period.
The United Kingdom, Germany, and France have strict animal health regulations that require regular vaccinations, which contributes to the high compliance rates among pet owners. According to CATS REPORT 2022 published by Cats Protection, cat ownership levels vary across the UK, ranging from 24% of households in Scotland owning one or more cats to 28% of households in Wales. The growing trend of adopting stray and rescued cats, which require thorough vaccination schedules, further boosts the market in this region. Thus, the Europe region is expected to capture more than 1/4th revenue share in the market by the year 2031. A well-established veterinary care system and high levels of pet ownership support Europe's market. Additionally, the market demand is stimulated by the extensive awareness campaigns that European veterinary associations and government bodies conduct to educate pet owners about the significance of vaccinations.
The increasing prevalence of feline diseases has become a significant concern for pet owners, veterinarians, and public health officials. Among the most notable diseases are the feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and rabies, all of which pose serious threats to the health and well-being of cats. This rise in disease incidence has heightened the urgency for effective vaccination programs to prevent potential outbreaks. Veterinarians also advocate for regular vaccination schedules to safeguard cats against these prevalent diseases. Therefore, the increasing prevalence of feline diseases has raised the demand for cat vaccines.
Additionally, the rising number of households adopting cats as pets has significantly increased the demand for cat vaccines. This tendency is affected by a number of different variables, including the growing urbanization, the shifting lifestyles, and the growing realization of the mental and companionship benefits that pets provide. The International Fund for Animal Welfare estimates that China is home to 58 million domestic cats, making Asia the home of the largest population of cats in the world, which accounts for 400 million out of a total population of 600 million. Hence, the increasing number of households adopting cats as pets has increased the demand for cat vaccines.
However, the lack of knowledge can be attributed to a variety of various problems, such as a general lack of concern for the health of pets in public discourse, an inadequate number of health campaigns, and an inadequate amount of access to veterinary care at the same time. In many developing countries, veterinary services are often concentrated in urban areas, leaving rural and remote communities with minimal access to professional advice and services. Hence, the lack of awareness and education about the importance of cat vaccinations is a significant obstacle to the growth of the cat vaccine market.
Moreover, the early stages of the pandemic undoubtedly caused a strain on the veterinary healthcare system. Lockdowns and social distancing measures often led to reduced clinic hours or temporary closures. This, in turn, likely resulted in a postponement or cancellation of non-essential appointments, including routine vaccinations for cats. Moreover, research into animal vaccines for COVID-19, while still in its early stages, suggests the potential for a future market dedicated specifically to cat COVID-19 vaccines. Thus, the pandemic had an overall moderate impact on the market.
Type Outlook
Based on type, the market is characterized into modified/attenuated live, inactivated (killed), and others. The modified/attenuated live segment garnered 48% revenue share in the market in 2023. The modified/attenuated live vaccine segment leads the cat vaccine market due to its ability to provide strong and long-lasting immunity with fewer doses. These vaccines stimulate a robust immune response, making them highly effective against feline herpesvirus (FHV) and feline calicivirus (FCV).
Disease Type Outlook
On the basis of disease type, the market is classified into feline leukemia, feline panleukopenia (feline distemper), feline respiratory diseases, feline rabies, and others. The feline leukemia segment recorded 10% revenue share in the market in 2023. Feline leukemia virus (FeLV) is a leading cause of death in domestic cats due to its impact on the immune system and its ability to cause cancer. The serious nature of FeLV and the availability of effective vaccines have driven pet owners to prioritize vaccination against this disease.
Route of Administration Outlook
By route of administration, the market is divided into injectables, intranasal, and oral. The intranasal segment garnered 15% revenue share in the market in 2023. Intranasal vaccines are particularly effective for respiratory diseases such as feline viral rhinotracheitis and calicivirus. These vaccines offer the advantage of inducing a local immune response in the respiratory tract, providing robust protection against pathogens that enter the nasal passages.
Duration of Immunity Outlook
Based on duration of immunity, the market is segmented into 1 year, 3 year, and others. The 1 year segment procured 49% revenue share in the market in 2023. These vaccines are typically used for core vaccinations such as feline viral rhinotracheitis, calicivirus, and panleukopenia, which require annual boosters to maintain effective immunity. The frequency of administration ensures that cats remain protected against common and potentially severe diseases, making these vaccines a staple in routine veterinary care.
Component Outlook
On the basis of component, the market is bifurcated into combined vaccines and mono vaccines. The combined vaccines segment recorded 62% revenue share in the market in 2023. These vaccines, which protect against multiple diseases in a single dose, are highly valued for their convenience and efficiency. By reducing the number of injections required, combined vaccines minimize the stress on cats and simplify the vaccination process for pet owners and veterinarians.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered 38% revenue share in the market in 2023. This region's dominance is driven by a high rate of pet ownership, advanced veterinary healthcare infrastructure, and strong awareness about pet health and vaccinations. In particular, the United States and Canada have robust regulatory frameworks and public health campaigns promoting regular pet vaccination schedules.
Recent Strategies Deployed in the Market
- May-2024: Boehringer Ingelheim has announced the approval of SENVELGO™ (velagliflozin oral solution) by Health Canada for the treatment of feline diabetes. This milestone signifies a significant advancement in the management of diabetes mellitus in cats within Canada. SENVELGO™, a liquid oral solution, introduces a revolutionary approach that eliminates the necessity for needles, thereby simplifying the treatment process for cats previously untreated with insulin. This innovation aims to enhance glycemic control and improve the overall management of feline diabetes, offering a more convenient and accessible treatment option for pet owners and veterinarians alike.
- Apr-2024: Zoetis launched Bonqat® (pregabalin oral solution) across veterinary clinics in the U.S. This introduction enhances Zoetis's range of products aimed at improving feline health, made available through an exclusive agreement with Orion Corporation. Bonqat represents a distinctive advancement in cat care, simplifying the process for pet owners to bring their cats to veterinary appointments. Additionally, it encourages more thorough care at clinics, encompassing diagnostics and preventative measures such as flea treatment, parasite control, and vaccination.
- Apr-2024: Virbac acquired Sasaeah, a leading animal health player in Japan. We successfully completed the acquisition of Sasaeah. This strategic acquisition brings Virbac a leadership position in the farm animal vaccines market in Japan, notably in the cattle segment, and a large portfolio of pharmaceutical products for all the major species.
- Sep-2022: Zoetis took over NewMetrica, develops health-related quality of life instruments, integrating health-related quality of life instruments into its companion animal portfolio. This strategic move aims to bolster capabilities throughout the care spectrum, deepen expertise in quality-of-life evaluations, and foster a deeper understanding of animal well-being. The addition of NewMetrica's tools and algorithms is anticipated to facilitate early disease detection and treatment, providing invaluable insights into the quality of life of pets. These advancements will play a crucial role in future product development efforts. The acquisition aligns closely with Zoetis's mission to enhance animal care, reflecting its commitment to promoting the well-being of animals and contributing positively to society and the environment.
- Sep-2022: Zoetis Inc. revealed Solensia™ (frunevetmab injection) throughout the U.S. This marks a significant advancement in pet pain management, particularly for osteoarthritis (OA). Solensia™ offers a groundbreaking approach by providing relief from OA pain through a single monthly injection administered directly in the veterinary clinic. This innovation aims to minimize the impact of OA pain, preserving the special bond between cats and their human companions without disruption. Zoetis is committed to collaborating closely with veterinarians to introduce this novel monoclonal antibody treatment, enhancing the quality of life for cats and supporting their well-being through effective and convenient pain management solutions.
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
By Component
- Combined Vaccines
- Mono Vaccines
- Injectables
- Intranasal
- Oral
- 1 Year
- 3 Year
- Others
- Feline Respiratory Diseases
- Feline Rabies
- Feline Panleukopenia (Feline Distemper)
- Feline Leukemia
- Others
- Modified/Attenuated Live
- Inactivated (Killed)
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
302 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Cat Vaccine Market, by Component
- 1.4.2 Global Cat Vaccine Market, by Route of Administration
- 1.4.3 Global Cat Vaccine Market, by Duration of Immunity
- 1.4.4 Global Cat Vaccine Market, by Disease Type
- 1.4.5 Global Cat Vaccine Market, by Type
- 1.4.6 Global Cat Vaccine Market, by Geography
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
- Chapter 4. Strategies Deployed in Cat Vaccine Market
- Chapter 5. Global Cat Vaccine Market by Component
- 5.1 Global Combined Vaccines Market by Region
- 5.2 Global Mono Vaccines Market by Region
- Chapter 6. Global Cat Vaccine Market by Route of Administration
- 6.1 Global Injectables Market by Region
- 6.2 Global Intranasal Market by Region
- 6.3 Global Oral Market by Region
- Chapter 7. Global Cat Vaccine Market by Duration of Immunity
- 7.1 Global 1 Year Market by Region
- 7.2 Global 3 Year Market by Region
- 7.3 Global Others Market by Region
- Chapter 8. Global Cat Vaccine Market by Disease Type
- 8.1 Global Feline Respiratory Diseases Market by Region
- 8.2 Global Feline Rabies Market by Region
- 8.3 Global Feline Panleukopenia (Feline Distemper) Market by Region
- 8.4 Global Feline Leukemia Market by Region
- 8.5 Global Others Market by Region
- Chapter 9. Global Cat Vaccine Market by Type
- 9.1 Global Modified/Attenuated Live Market by Region
- 9.2 Global Inactivated (Killed) Market by Region
- 9.3 Global Others Market by Region
- Chapter 10. Global Cat Vaccine Market by Region
- 10.1 North America Cat Vaccine Market
- 10.1.1 North America Cat Vaccine Market by Component
- 10.1.1.1 North America Combined Vaccines Market by Region
- 10.1.1.2 North America Mono Vaccines Market by Region
- 10.1.2 North America Cat Vaccine Market by Route of Administration
- 10.1.2.1 North America Injectables Market by Country
- 10.1.2.2 North America Intranasal Market by Country
- 10.1.2.3 North America Oral Market by Country
- 10.1.3 North America Cat Vaccine Market by Duration of Immunity
- 10.1.3.1 North America 1 Year Market by Country
- 10.1.3.2 North America 3 Year Market by Country
- 10.1.3.3 North America Others Market by Country
- 10.1.4 North America Cat Vaccine Market by Disease Type
- 10.1.4.1 North America Feline Respiratory Diseases Market by Country
- 10.1.4.2 North America Feline Rabies Market by Country
- 10.1.4.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
- 10.1.4.4 North America Feline Leukemia Market by Country
- 10.1.4.5 North America Others Market by Country
- 10.1.5 North America Cat Vaccine Market by Type
- 10.1.5.1 North America Modified/Attenuated Live Market by Country
- 10.1.5.2 North America Inactivated (Killed) Market by Country
- 10.1.5.3 North America Others Market by Country
- 10.1.6 North America Cat Vaccine Market by Country
- 10.1.6.1 US Cat Vaccine Market
- 10.1.6.1.1 US Cat Vaccine Market by Component
- 10.1.6.1.2 US Cat Vaccine Market by Route of Administration
- 10.1.6.1.3 US Cat Vaccine Market by Duration of Immunity
- 10.1.6.1.4 US Cat Vaccine Market by Disease Type
- 10.1.6.1.5 US Cat Vaccine Market by Type
- 10.1.6.2 Canada Cat Vaccine Market
- 10.1.6.2.1 Canada Cat Vaccine Market by Component
- 10.1.6.2.2 Canada Cat Vaccine Market by Route of Administration
- 10.1.6.2.3 Canada Cat Vaccine Market by Duration of Immunity
- 10.1.6.2.4 Canada Cat Vaccine Market by Disease Type
- 10.1.6.2.5 Canada Cat Vaccine Market by Type
- 10.1.6.3 Mexico Cat Vaccine Market
- 10.1.6.3.1 Mexico Cat Vaccine Market by Component
- 10.1.6.3.2 Mexico Cat Vaccine Market by Route of Administration
- 10.1.6.3.3 Mexico Cat Vaccine Market by Duration of Immunity
- 10.1.6.3.4 Mexico Cat Vaccine Market by Disease Type
- 10.1.6.3.5 Mexico Cat Vaccine Market by Type
- 10.1.6.4 Rest of North America Cat Vaccine Market
- 10.1.6.4.1 Rest of North America Cat Vaccine Market by Component
- 10.1.6.4.2 Rest of North America Cat Vaccine Market by Route of Administration
- 10.1.6.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
- 10.1.6.4.4 Rest of North America Cat Vaccine Market by Disease Type
- 10.1.6.4.5 Rest of North America Cat Vaccine Market by Type
- 10.2 Europe Cat Vaccine Market
- 10.2.1 Europe Cat Vaccine Market by Component
- 10.2.1.1 Europe Combined Vaccines Market by Country
- 10.2.1.2 Europe Mono Vaccines Market by Country
- 10.2.2 Europe Cat Vaccine Market by Route of Administration
- 10.2.2.1 Europe Injectables Market by Country
- 10.2.2.2 Europe Intranasal Market by Country
- 10.2.2.3 Europe Oral Market by Country
- 10.2.3 Europe Cat Vaccine Market by Duration of Immunity
- 10.2.3.1 Europe 1 Year Market by Country
- 10.2.3.2 Europe 3 Year Market by Country
- 10.2.3.3 Europe Others Market by Country
- 10.2.4 Europe Cat Vaccine Market by Disease Type
- 10.2.4.1 Europe Feline Respiratory Diseases Market by Country
- 10.2.4.2 Europe Feline Rabies Market by Country
- 10.2.4.3 Europe Feline Panleukopenia (Feline Distemper) Market by Country
- 10.2.4.4 Europe Feline Leukemia Market by Country
- 10.2.4.5 Europe Others Market by Country
- 10.2.5 Europe Cat Vaccine Market by Type
- 10.2.5.1 Europe Modified/Attenuated Live Market by Country
- 10.2.5.2 Europe Inactivated (Killed) Market by Country
- 10.2.5.3 Europe Others Market by Country
- 10.2.6 Europe Cat Vaccine Market by Country
- 10.2.6.1 Germany Cat Vaccine Market
- 10.2.6.1.1 Germany Cat Vaccine Market by Component
- 10.2.6.1.2 Germany Cat Vaccine Market by Route of Administration
- 10.2.6.1.3 Germany Cat Vaccine Market by Duration of Immunity
- 10.2.6.1.4 Germany Cat Vaccine Market by Disease Type
- 10.2.6.1.5 Germany Cat Vaccine Market by Type
- 10.2.6.2 UK Cat Vaccine Market
- 10.2.6.2.1 UK Cat Vaccine Market by Component
- 10.2.6.2.2 UK Cat Vaccine Market by Route of Administration
- 10.2.6.2.3 UK Cat Vaccine Market by Duration of Immunity
- 10.2.6.2.4 UK Cat Vaccine Market by Disease Type
- 10.2.6.2.5 UK Cat Vaccine Market by Type
- 10.2.6.3 France Cat Vaccine Market
- 10.2.6.3.1 France Cat Vaccine Market by Component
- 10.2.6.3.2 France Cat Vaccine Market by Route of Administration
- 10.2.6.3.3 France Cat Vaccine Market by Duration of Immunity
- 10.2.6.3.4 France Cat Vaccine Market by Disease Type
- 10.2.6.3.5 France Cat Vaccine Market by Type
- 10.2.6.4 Russia Cat Vaccine Market
- 10.2.6.4.1 Russia Cat Vaccine Market by Component
- 10.2.6.4.2 Russia Cat Vaccine Market by Route of Administration
- 10.2.6.4.3 Russia Cat Vaccine Market by Duration of Immunity
- 10.2.6.4.4 Russia Cat Vaccine Market by Disease Type
- 10.2.6.4.5 Russia Cat Vaccine Market by Type
- 10.2.6.5 Spain Cat Vaccine Market
- 10.2.6.5.1 Spain Cat Vaccine Market by Component
- 10.2.6.5.2 Spain Cat Vaccine Market by Route of Administration
- 10.2.6.5.3 Spain Cat Vaccine Market by Duration of Immunity
- 10.2.6.5.4 Spain Cat Vaccine Market by Disease Type
- 10.2.6.5.5 Spain Cat Vaccine Market by Type
- 10.2.6.6 Italy Cat Vaccine Market
- 10.2.6.6.1 Italy Cat Vaccine Market by Component
- 10.2.6.6.2 Italy Cat Vaccine Market by Route of Administration
- 10.2.6.6.3 Italy Cat Vaccine Market by Duration of Immunity
- 10.2.6.6.4 Italy Cat Vaccine Market by Disease Type
- 10.2.6.6.5 Italy Cat Vaccine Market by Type
- 10.2.6.7 Rest of Europe Cat Vaccine Market
- 10.2.6.7.1 Rest of Europe Cat Vaccine Market by Component
- 10.2.6.7.2 Rest of Europe Cat Vaccine Market by Route of Administration
- 10.2.6.7.3 Rest of Europe Cat Vaccine Market by Duration of Immunity
- 10.2.6.7.4 Rest of Europe Cat Vaccine Market by Disease Type
- 10.2.6.7.5 Rest of Europe Cat Vaccine Market by Type
- 10.3 Asia Pacific Cat Vaccine Market
- 10.3.1 Asia Pacific Cat Vaccine Market by Component
- 10.3.1.1 Asia Pacific Combined Vaccines Market by Country
- 10.3.1.2 Asia Pacific Mono Vaccines Market by Country
- 10.3.2 Asia Pacific Cat Vaccine Market by Route of Administration
- 10.3.2.1 Asia Pacific Injectables Market by Country
- 10.3.2.2 Asia Pacific Intranasal Market by Country
- 10.3.2.3 Asia Pacific Oral Market by Country
- 10.3.3 Asia Pacific Cat Vaccine Market by Duration of Immunity
- 10.3.3.1 Asia Pacific 1 Year Market by Country
- 10.3.3.2 Asia Pacific 3 Year Market by Country
- 10.3.3.3 Asia Pacific Others Market by Country
- 10.3.4 Asia Pacific Cat Vaccine Market by Disease Type
- 10.3.4.1 Asia Pacific Feline Respiratory Diseases Market by Country
- 10.3.4.2 Asia Pacific Feline Rabies Market by Country
- 10.3.4.3 Asia Pacific Feline Panleukopenia (Feline Distemper) Market by Country
- 10.3.4.4 Asia Pacific Feline Leukemia Market by Country
- 10.3.4.5 Asia Pacific Others Market by Country
- 10.3.5 Asia Pacific Cat Vaccine Market by Type
- 10.3.5.1 Asia Pacific Modified/Attenuated Live Market by Country
- 10.3.5.2 Asia Pacific Inactivated (Killed) Market by Country
- 10.3.5.3 Asia Pacific Others Market by Country
- 10.3.6 Asia Pacific Cat Vaccine Market by Country
- 10.3.6.1 China Cat Vaccine Market
- 10.3.6.1.1 China Cat Vaccine Market by Component
- 10.3.6.1.2 China Cat Vaccine Market by Route of Administration
- 10.3.6.1.3 China Cat Vaccine Market by Duration of Immunity
- 10.3.6.1.4 China Cat Vaccine Market by Disease Type
- 10.3.6.1.5 China Cat Vaccine Market by Type
- 10.3.6.2 Japan Cat Vaccine Market
- 10.3.6.2.1 Japan Cat Vaccine Market by Component
- 10.3.6.2.2 Japan Cat Vaccine Market by Route of Administration
- 10.3.6.2.3 Japan Cat Vaccine Market by Duration of Immunity
- 10.3.6.2.4 Japan Cat Vaccine Market by Disease Type
- 10.3.6.2.5 Japan Cat Vaccine Market by Type
- 10.3.6.3 India Cat Vaccine Market
- 10.3.6.3.1 India Cat Vaccine Market by Component
- 10.3.6.3.2 India Cat Vaccine Market by Route of Administration
- 10.3.6.3.3 India Cat Vaccine Market by Duration of Immunity
- 10.3.6.3.4 India Cat Vaccine Market by Disease Type
- 10.3.6.3.5 India Cat Vaccine Market by Type
- 10.3.6.4 South Korea Cat Vaccine Market
- 10.3.6.4.1 South Korea Cat Vaccine Market by Component
- 10.3.6.4.2 South Korea Cat Vaccine Market by Route of Administration
- 10.3.6.4.3 South Korea Cat Vaccine Market by Duration of Immunity
- 10.3.6.4.4 South Korea Cat Vaccine Market by Disease Type
- 10.3.6.4.5 South Korea Cat Vaccine Market by Type
- 10.3.6.5 Singapore Cat Vaccine Market
- 10.3.6.5.1 Singapore Cat Vaccine Market by Component
- 10.3.6.5.2 Singapore Cat Vaccine Market by Route of Administration
- 10.3.6.5.3 Singapore Cat Vaccine Market by Duration of Immunity
- 10.3.6.5.4 Singapore Cat Vaccine Market by Disease Type
- 10.3.6.5.5 Singapore Cat Vaccine Market by Type
- 10.3.6.6 Malaysia Cat Vaccine Market
- 10.3.6.6.1 Malaysia Cat Vaccine Market by Component
- 10.3.6.6.2 Malaysia Cat Vaccine Market by Route of Administration
- 10.3.6.6.3 Malaysia Cat Vaccine Market by Duration of Immunity
- 10.3.6.6.4 Malaysia Cat Vaccine Market by Disease Type
- 10.3.6.6.5 Malaysia Cat Vaccine Market by Type
- 10.3.6.7 Rest of Asia Pacific Cat Vaccine Market
- 10.3.6.7.1 Rest of Asia Pacific Cat Vaccine Market by Component
- 10.3.6.7.2 Rest of Asia Pacific Cat Vaccine Market by Route of Administration
- 10.3.6.7.3 Rest of Asia Pacific Cat Vaccine Market by Duration of Immunity
- 10.3.6.7.4 Rest of Asia Pacific Cat Vaccine Market by Disease Type
- 10.3.6.7.5 Rest of Asia Pacific Cat Vaccine Market by Type
- 10.4 LAMEA Cat Vaccine Market
- 10.4.1 LAMEA Cat Vaccine Market by Component
- 10.4.1.1 LAMEA Combined Vaccines Market by Country
- 10.4.1.2 LAMEA Mono Vaccines Market by Country
- 10.4.2 LAMEA Cat Vaccine Market by Route of Administration
- 10.4.2.1 LAMEA Injectables Market by Country
- 10.4.2.2 LAMEA Intranasal Market by Country
- 10.4.2.3 LAMEA Oral Market by Country
- 10.4.3 LAMEA Cat Vaccine Market by Duration of Immunity
- 10.4.3.1 LAMEA 1 Year Market by Country
- 10.4.3.2 LAMEA 3 Year Market by Country
- 10.4.3.3 LAMEA Others Market by Country
- 10.4.4 LAMEA Cat Vaccine Market by Disease Type
- 10.4.4.1 LAMEA Feline Respiratory Diseases Market by Country
- 10.4.4.2 LAMEA Feline Rabies Market by Country
- 10.4.4.3 LAMEA Feline Panleukopenia (Feline Distemper) Market by Country
- 10.4.4.4 LAMEA Feline Leukemia Market by Country
- 10.4.4.5 LAMEA Others Market by Country
- 10.4.5 LAMEA Cat Vaccine Market by Type
- 10.4.5.1 LAMEA Modified/Attenuated Live Market by Country
- 10.4.5.2 LAMEA Inactivated (Killed) Market by Country
- 10.4.5.3 LAMEA Others Market by Country
- 10.4.6 LAMEA Cat Vaccine Market by Country
- 10.4.6.1 Brazil Cat Vaccine Market
- 10.4.6.1.1 Brazil Cat Vaccine Market by Component
- 10.4.6.1.2 Brazil Cat Vaccine Market by Route of Administration
- 10.4.6.1.3 Brazil Cat Vaccine Market by Duration of Immunity
- 10.4.6.1.4 Brazil Cat Vaccine Market by Disease Type
- 10.4.6.1.5 Brazil Cat Vaccine Market by Type
- 10.4.6.2 Argentina Cat Vaccine Market
- 10.4.6.2.1 Argentina Cat Vaccine Market by Component
- 10.4.6.2.2 Argentina Cat Vaccine Market by Route of Administration
- 10.4.6.2.3 Argentina Cat Vaccine Market by Duration of Immunity
- 10.4.6.2.4 Argentina Cat Vaccine Market by Disease Type
- 10.4.6.2.5 Argentina Cat Vaccine Market by Type
- 10.4.6.3 UAE Cat Vaccine Market
- 10.4.6.3.1 UAE Cat Vaccine Market by Component
- 10.4.6.3.2 UAE Cat Vaccine Market by Route of Administration
- 10.4.6.3.3 UAE Cat Vaccine Market by Duration of Immunity
- 10.4.6.3.4 UAE Cat Vaccine Market by Disease Type
- 10.4.6.3.5 UAE Cat Vaccine Market by Type
- 10.4.6.4 Saudi Arabia Cat Vaccine Market
- 10.4.6.4.1 Saudi Arabia Cat Vaccine Market by Component
- 10.4.6.4.2 Saudi Arabia Cat Vaccine Market by Route of Administration
- 10.4.6.4.3 Saudi Arabia Cat Vaccine Market by Duration of Immunity
- 10.4.6.4.4 Saudi Arabia Cat Vaccine Market by Disease Type
- 10.4.6.4.5 Saudi Arabia Cat Vaccine Market by Type
- 10.4.6.5 South Africa Cat Vaccine Market
- 10.4.6.5.1 South Africa Cat Vaccine Market by Component
- 10.4.6.5.2 South Africa Cat Vaccine Market by Route of Administration
- 10.4.6.5.3 South Africa Cat Vaccine Market by Duration of Immunity
- 10.4.6.5.4 South Africa Cat Vaccine Market by Disease Type
- 10.4.6.5.5 South Africa Cat Vaccine Market by Type
- 10.4.6.6 Nigeria Cat Vaccine Market
- 10.4.6.6.1 Nigeria Cat Vaccine Market by Component
- 10.4.6.6.2 Nigeria Cat Vaccine Market by Route of Administration
- 10.4.6.6.3 Nigeria Cat Vaccine Market by Duration of Immunity
- 10.4.6.6.4 Nigeria Cat Vaccine Market by Disease Type
- 10.4.6.6.5 Nigeria Cat Vaccine Market by Type
- 10.4.6.7 Rest of LAMEA Cat Vaccine Market
- 10.4.6.7.1 Rest of LAMEA Cat Vaccine Market by Component
- 10.4.6.7.2 Rest of LAMEA Cat Vaccine Market by Route of Administration
- 10.4.6.7.3 Rest of LAMEA Cat Vaccine Market by Duration of Immunity
- 10.4.6.7.4 Rest of LAMEA Cat Vaccine Market by Disease Type
- 10.4.6.7.5 Rest of LAMEA Cat Vaccine Market by Type
- Chapter 11. Company Profiles
- 11.1 Zoetis, Inc.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.5.2 Product Launches and Product Expansions:
- 11.1.5.3 Acquisition and Mergers:
- 11.1.6 SWOT Analysis
- 11.2 Elanco Animal Health, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expenses
- 11.2.5 SWOT Analysis
- 11.3 Merck & Co., Inc.
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 SWOT Analysis
- 11.4 Boehringer Ingelheim International GmbH
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Regional & Segmental Analysis
- 11.4.4 Research & Development Expenses
- 11.4.5 Recent strategies and developments:
- 11.4.5.1 Trials and Approvals:
- 11.4.6 SWOT Analysis
- 11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- 11.5.1 Company Overview
- 11.5.2 SWOT Analysis
- 11.6 Virbac
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Recent strategies and developments:
- 11.6.4.1 Acquisition and Mergers:
- 11.6.5 SWOT Analysis
- 11.7 Heska Corporation (Antech Diagnostics, Inc)
- 11.7.1 Company Overview
- 11.7.2 SWOT Analysis
- 11.8 Ceva Sante Animale
- 11.8.1 Company Overview
- 11.8.2 SWOT Analysis
- 11.9 Bioveta, a.s.
- 11.9.1 Company Overview
- Chapter 12. Winning Imperatives of Cat Vaccine Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.